Second Remission
Second Remission is a clinical state in oncology, specifically within the context of relapsed disease, denoting the restoration of disease control or absence of detectable malignancy following successful re-induction therapy after a prior relapse.
535
Publications
29.2K
Citations
3.7K
Authors
1.2K
Institutions
Publications per year
2017–2026
79
Parents
535
Antileukemic Effect of Chronic Graft-versus-Host Disease
Paul L. Weiden, Keith M. Sullivan, Nancy Flournoy et al. · New England Journal of Medicine · 1981 · 1.1K citations
Medicine, Hematology, Oncology +14
Andrew M. Yeager, Herbert Kaizer, George W. Santos et al. · New England Journal of Medicine · 1986 · 441 citations
Medicine, Hematology, Oncology +13
Christoph Schmid, Michael Schleuning, Georg Ledderose et al. · Journal of Clinical Oncology · 2005 · 419 citations
Medicine, Oncology, Cell Therapy +15
1–5 of 535
3.7K
14
h-index
13
h-index
12
h-index
11
h-index
9
h-index
1–5 of 3.7K
1.2K
Memorial Sloan Kettering Cancer Center
New York, United States
22 h-index
132 publications
9.4K citations

Medical College of Wisconsin
Milwaukee, United States
18 h-index
65 publications
5.4K citations

Sorbonne Université
Paris, France
18 h-index
73 publications
2.8K citations

St. Jude Children's Research Hospital
Memphis, United States
16 h-index
64 publications
3.6K citations
Hôpital Saint-Antoine
Paris, France
15 h-index
47 publications
1.6K citations
The University of Texas MD Anderson Cancer Center
Houston, United States
15 h-index
149 publications
10.2K citations

University of Minnesota
Minneapolis, United States
15 h-index
80 publications
4.3K citations
University College London
London, United Kingdom
15 h-index
43 publications
2.2K citations
1–8 of 1.2K
38 publications · 4.6K citations
33
h-index
BJH · 58 publications · 2.4K citations
29
h-index
40 publications · 2.1K citations
28
h-index
TCT · 25 publications · 1.4K citations
21
h-index
27 publications · 1.1K citations
20
h-index
1–5